Cargando…
Kadsurenone is a useful and promising treatment strategy for breast cancer bone metastases by blocking the PAF/PTAFR signaling pathway
Breast cancer (BC) is characterized by high incidences of bone metastases. Current treatment strategies for BC bone metastases primarily focused on breaking the ‘vicious osteolytic cycle’. Platelet-activating factor (PAF) is a potent phospholipid mediator, which has previously reported biological ac...
Autores principales: | Hou, Tianhui, Lou, Yan, Li, Shichang, Zhao, Chenglong, Ji, Yingzheng, Wang, Dongsheng, Tang, Liang, Zhou, Ming, Xu, Wei, Qian, Ming, Wu, Zhipeng, Zhao, Jian, Wei, Haifeng, Li, Zhenxi, Xiao, Jianru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036417/ https://www.ncbi.nlm.nih.gov/pubmed/30008927 http://dx.doi.org/10.3892/ol.2018.8935 |
Ejemplares similares
-
Outcomes and prognostic factors for surgically treated patients with breast cancer spine metastases
por: Zhao, Chenglong, et al.
Publicado: (2018) -
NPNT promotes early-stage bone metastases in breast cancer by regulation of the osteogenic niche
por: Wang, Dongsheng, et al.
Publicado: (2018) -
Role of betulinic acid derivative SH-479 in triple negative breast cancer and bone microenvironment
por: Tang, Liang, et al.
Publicado: (2021) -
A gene expression signature‐based nomogram model in prediction of breast cancer bone metastases
por: Zhao, Chenglong, et al.
Publicado: (2018) -
Prognostic Significance of a Novel Score Model Based on Preoperative Indicators in Patients with Breast Cancer Spine Metastases (BCSM)
por: Zhao, Chenglong, et al.
Publicado: (2020)